More Fields

Filters

Profiles which have:

Recent Changes

Profiles with recent changes to:
Sign up to Download

1-4 of 4 results

  • zymedyne.ca
  • 3
Zymedyne aims to develop safer, more effective treatments for chronic, neuropathic pain by targeting human Cav3.2 "T-type" calcium channels that are known to be crucial in pain signalling. Unlike opioids, our technology aims to achieve pain relief..
Relevance: 24.018574
  • www.pharmixon.com
  • 1
  • 1
  • 8
Pharmixon is a Biotechnology venture active in creating innovative therapeutics focused in Onco-Channelopathies... Pharmixon is developing small molecules and biologics able to block Calcium and Potassium Channel-derived malignancies which can..
Relevance: 16.689907
  • www.onkion-bio.com
  • 1
  • 1
  • 11
Onkion is a Biotechnology venture active in creating innovative therapeutics focused in Onco-Channelopathies... Onkion SA is developing humanized monoclonal antibodies and antibody fragments capable to block Calcium and Potassium Channel-derived..
Relevance: 14.769681
  • cumming.ucalgary.ca
  • 106
  • 58
  • 141
The CSM Indigenous, Local and Global Health office exists to facilitate education, research and engagement efforts that build health equity at home and abroad, and to draw from experience to offer best-evidence resources that enable students, staff..
Relevance: 5.42872